BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs

被引:8
作者
AbuZidan, FM
Walther, S
Lennquist, S
机构
[1] Department of Surgery, University Hospital
来源
PHARMACOLOGY & TOXICOLOGY | 1996年 / 78卷 / 01期
关键词
D O I
10.1111/j.1600-0773.1996.tb00175.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of bolus doses (0.2-2 mu g) of platelet-activating factor (PAF) on systemic and pulmonary arterial pressures were tested in five juvenile pigs, and were demonstrated to have a biphasic effect. There was an initial drop in the mean systemic arterial pressure within seconds, followed by an increase within 1-2 min., whereas mean pulmonary arterial pressure only rose. The response was dose-related and did not include tachyphylaxis. The pressures returned to baseline within 10 min. After confirming these results a novel specific PAF receptor antagonist (BB-882) was given as a 1 mg/kg bolus followed by a continous infusion of 2. mg/kg/hr, and a third dose response curve was repeated with ten-fold higher PAF doses (2-20 mu g). BB-882 effectively counteracted these effects. Six pigs were given a continous infusion of BB-882 33 mg/kg/hr for 5 hr and were compared with another group of five pigs given vehicle only. In this high dose BB-882 did not affect the intravascular pressures. These results indicate that BB-882 is a potent PAF receptor antagonist in juvenile pigs.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 33 条
  • [1] ABUZIDAN FM, 1994, CIRC SHOCK, V44, P148
  • [2] ABUZIDAN FM, 1995, IN PRESS EUR SURG RE
  • [3] ABUZIDAN FM, 1995, IN PRESS EUR J SURG
  • [4] ANDERSEN B, 1984, PROBLEMS P SIGNIFICA, P63
  • [5] ANGLE MJ, 1987, LAB INVEST, V57, P321
  • [6] ACUTE CIRCULATORY COLLAPSE CAUSED BY PLATELET-ACTIVATING FACTOR (PAF-ACETHER) IN DOGS
    BESSIN, P
    BONNET, J
    APFFEL, D
    SOULARD, C
    DESGROUX, L
    PELAS, I
    BENVENISTE, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 86 (3-4) : 403 - 413
  • [7] PAF-ACETHER (PLATELET-ACTIVATING FACTOR) INCREASES MICROVASCULAR PERMEABILITY AND AFFECTS ENDOTHELIUM-GRANULOCYTE INTERACTION IN MICROVASCULAR BEDS
    BJORK, J
    LINDBOM, L
    GERDIN, B
    SMEDEGARD, G
    ARFORS, KE
    BENVENISTE, J
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (03): : 305 - 308
  • [8] PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS
    BRAQUET, P
    GODFROID, JJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) : 397 - 403
  • [9] NEW TRENDS IN PAF ANTAGONIST RESEARCH - A NEW SERIES OF POTENT HETRAPAZINE-DERIVED PAF ANTAGONISTS
    BRAQUET, P
    ESANU, A
    [J]. AGENTS AND ACTIONS, 1991, 32 (1-2): : 34 - 36
  • [10] CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974